Methods and compositions involving miRNA and miRNA inhibitor molecules

US9051571B2 · kind B2 · utility

Assignee

• ASURAGEN, INC. · US

Inventors

• David Brown · Brighton, US
• Lance Ford · Austin, US
• Angie Cheng · Austin, US
• Rich Jarvis · Austin, US
• Mike Byrom · Austin, US
• Dmitriy Ovcharenko · Austin, US
• Eric Devroe · Pflugerville, US
• Kevin Kelnar · Kyle, US

Key dates

• Filing date: Apr 16, 2014
• Grant date: Jun 9, 2015
• Expiry date: Apr 16, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/178
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.